# Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

> clinical trial · VERIFIED · 2026-06-17

Status: RECRUITING · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) · Condition: Hyper IgE Syndrome From STAT3 Mutation

- Company: National Institute of Allergy and Infectious Diseases (NIAID)
- Sector: immunology
- Primary source: https://clinicaltrials.gov/study/NCT07262983

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.